Health
Experimental Mesothelioma Drug Disables Tumor’s Antioxidant Shield
A new drug targeting PRX3 has controlled disease progression in 67% of mesothelioma patients, turning the cancer's defense mechanisms against it.
Tag: PRX3
Yovao News · The World, In Focus.
From Local to Global, Never Miss a Beat